chr6-90516542-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_145331.3(MAP3K7):c.1780G>A(p.Val594Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000062 in 1,612,234 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V594D) has been classified as Uncertain significance.
Frequency
Consequence
NM_145331.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAP3K7 | NM_145331.3 | c.1780G>A | p.Val594Ile | missense_variant | 17/17 | ENST00000369329.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAP3K7 | ENST00000369329.8 | c.1780G>A | p.Val594Ile | missense_variant | 17/17 | 1 | NM_145331.3 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151836Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000799 AC: 2AN: 250456Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135344
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460398Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726496
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151836Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74174
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.1780G>A (p.V594I) alteration is located in exon 17 (coding exon 17) of the MAP3K7 gene. This alteration results from a G to A substitution at nucleotide position 1780, causing the valine (V) at amino acid position 594 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at